Catalyst Pharmaceuticals, Inc.

341 articles about Catalyst Pharmaceuticals, Inc.

• Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index

  6/25/2008

• Catalyst Pharmaceutical Partners Files Form S-3 Shelf Registration Statement

  6/3/2008

• Catalyst Pharmaceutical Partners Names Director

  3/5/2008

• Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial

  1/25/2008

• Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction

  12/7/2007

• Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results

  11/15/2007

• Catalyst Pharmaceutical Partners to Present at The Roth Capital Partners 2007 New York Conference

  8/29/2007

• Catalyst Pharmaceutical Partners Reports Second Quarter 2007 Financial Results

  8/13/2007

• Catalyst Pharmaceutical Partners Initiates U.S. Phase II Clinical Trial of CPP-109 in Patients With Cocaine Dependence

  7/10/2007

• Catalyst Pharmaceutical Partners Reports First Quarter 2007 Financial Results

  5/15/2007

• Catalyst Pharmaceutical Partners Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's Investigational Drug to Treat Cocaine and Methamphetamine Addiction

  5/9/2007

• Catalyst Pharmaceutical Partners Names Vice President of Pharmaceutical Development and Project Management

  4/4/2007

• Catalyst Pharmaceutical Partners Reports Year-End 2006 Financial Results

  4/3/2007

• Catalyst Pharmaceutical Partners Strengthens Scientific Advisory Board With Appointment Of Richard A. Rawson, Ph.D.

  2/14/2007

• Catalyst Pharmaceutical Partners Adds Thomas Kosten, M.D. To Its Scientific Advisory Board

  1/12/2007

• Catalyst Pharmaceutical Partners Trial Delayed

  1/3/2007

• Catalyst Pharmaceutical Partners Announces Results Of Operations For 2006 Third Quarter

  12/18/2006

• Catalyst Pharmaceutical Partners Announces Closing Of Initial Public Offering

  11/14/2006

• IPO Watch: Is Catalyst Pharmaceutical Partners A Bargain At Half The Price?

  11/10/2006

• The Day In Review: News From The Hepatitis Front

  10/27/2006